Although several preclinical studies supported AURKA as a therapeutic target for cancers (92, 93), further studies are required to establish the role of AURKA in adipose development and its implication for obesity using an animal model on a large scale and in humans. This evidence concerns the gene AURKA and obesity due to melanocortin 4 receptor deficiency.